Quantifying Disease Severity in Health Technology Assessment in Japan: A Retrospective Analysis Using Quality-Adjusted Life-Year Shortfalls
QALY shortfalls may serve as a complementary approach to identifying unmet health needs within Japan's HTA system. To ensure methodological robustness and social acceptance, broader validation, standardized estimation methods, and stakeholder consensus are necessary for effective decision-making.
Authors
- Akira Yuasa (ORCID: https://orcid.org/0000-0002-3699-7231)
- Shunya Ikeda (ORCID: https://orcid.org/0000-0002-1866-2155)
- Miwa Sonoda (ORCID: https://orcid.org/0000-0002-3729-9275)
Institutions
- Pfizer (Japan) (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Journal of health economics and outcomes research
- Published
- 2025-12-02
- DOI
- https://doi.org/10.36469/001c.147469
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Pfizer Japan